Literature DB >> 16911394

Oral lichen planus: clinical and histological evaluation in an open trial using a low molecular weight heparinoid (sulodexide).

Felice Femiano, Crispian Scully.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16911394     DOI: 10.1111/j.1365-4632.2006.02740.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  2 in total

1.  A topical heparinoid-containing product improves epidermal permeability barrier homeostasis in mice.

Authors:  Ye Yao; Pan Guo; Xiaoyue Feng; Chunping Shen; Junkai Huang; Jiechen Zhang; Peter M Elias; Lizhi Hu; Mao-Qiang Man
Journal:  Exp Dermatol       Date:  2019-07-04       Impact factor: 3.960

2.  Comparison of therapeutic effect of low-dose low-molecular-weight heparin (enoxaparin) vs. oral prednisone in treatment of patients with lichen planus; A clinical trial.

Authors:  Fariba Iraji; Ali Asilian; Ahmad Saeidi; Amir Hossein Siadat; Ali Reza Saeidi; Akbar Hassanzadeh
Journal:  Adv Biomed Res       Date:  2013-07-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.